| # | Side effect | Count |
|---|---|---|
| 0 | PRODUCT USE IN UNAPPROVED INDICATION | 294 |
| 1 | OFF LABEL USE | 170 |
| 2 | LIVER ABSCESS | 73 |
| 3 | PYREXIA | 59 |
| 4 | PULMONARY EMBOLISM | 49 |
| 5 | PRODUCT USE ISSUE | 43 |
| 6 | ASPARTATE AMINOTRANSFERASE INCREASED | 40 |
| 7 | PANCYTOPENIA | 36 |
| 8 | ALANINE AMINOTRANSFERASE INCREASED | 35 |
| 9 | DISEASE PROGRESSION | 33 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | URINE IODINE INCREASED | 8 | 0.3333 |
| 1 | HEPATIC ARTERY STENOSIS | 30 | 0.2308 |
| 2 | POST EMBOLISATION SYNDROME | 24 | 0.2087 |
| 3 | HEPATIC ARTERY OCCLUSION | 11 | 0.1294 |
| 4 | BILOMA | 18 | 0.1277 |
| 5 | PULMONARY OIL MICROEMBOLISM | 8 | 0.0748 |
| 6 | HEPATIC INFARCTION | 11 | 0.0292 |
| 7 | CEREBRAL ARTERY EMBOLISM | 28 | 0.0230 |
| 8 | LIVER ABSCESS | 73 | 0.0225 |
| 9 | ABDOMINAL INJURY | 10 | 0.0192 |